| DEUTETRABENAZINE | Teva | ||
| 6MG, 12MG, 24MG, 30MG, 36MG, 42MG, 48MG, 18MG ; TABLET,EXTENDED RELEASE |
Less Than $1000 mn
|
||
| None | None | ||
|
More Than 5
|
None | ||
| None | None | ||
| AUSTEDO XR is vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia | |||
|
Yes
| |||
| AUSTEDO XR | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ************** ********** ** ********* ********* *********** * | ************ **************** ** ********** ************** ********** ** ********* ********* *********** * | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* ** ****************, ***** *********** *** *** | ******* ** ****************, ***** *********** *** *** | ******* ****** ***** ********** **************** *** ******* ** *** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|